Author:
Crawford E. David,Rosenberg Matt T.,Partin Alan W.,Cooperberg Matthew R.,Maccini Michael,Loeb Stacy,Pettaway Curtis A.,Shore Neal D.,Arangua Paul,Hoenemeyer John,Leveridge Mike,Leapman Michael,Pinto Peter,Thompson Ian M.,Carroll Peter,Eastham James,Gomella Leonard,Klein Eric A.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Point-Counterpoint: Screening vs Diagnostic Testing: A Focus on the Improved Evaluations and Risk Adapted Strategies for Prostate Biopsy;Urology Practice;2023-03
2. Is There A Prognostic Significance For Copper, Beryllium, Boron, Titanium And Vanadium Ions In Prostate Cancer?;Balıkesır Health Sciences Journal;2022-01-10
3. PSA: role in screening and monitoring patients with prostate cancer;Cancer Biomarkers;2022
4. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial;The Lancet Oncology;2021-09
5. Clinical Utility of 4Kscore
®
, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer;Journal of Urology;2021-02